Liability for damage caused by medicinal products is regulated in the sixteenth section of the AMG in Sections 84 ff. If a pharmaceutical company places a medicinal product on the market within the scope of this Act, it is obliged to compensate the injured party for the resulting damage.
The scope of the obligation to pay compensation in the event of death or personal injury and the statutory maximum amounts can be found in Sections 86 - 89.
Finally, Section 94 regulates the details of the coverage to be provided (product liability insurance).
These requirements must be met by all companies that place medicinal products on the market in Germany. It does not matter whether they are based inside or outside the European Union.
We are very familiar with this issue and can help you.
